-
公开(公告)号:US20220213449A1
公开(公告)日:2022-07-07
申请号:US17646212
申请日:2021-12-28
发明人: Vipin SURI , Dan Jun LI , Dexue SUN , Byron DELABARRE , Vijaya BALAKRISHNAN , Brian DOLINSKI , Mara Christine INNISS , Grace Y. OLINGER
IPC分类号: C12N9/06 , C07K14/54 , C07K14/715 , C12N15/85 , A61K35/17 , C07K14/705
摘要: The present invention is related to compositions and methods for the regulated and controlled expression of proteins.
-
公开(公告)号:US20200172879A1
公开(公告)日:2020-06-04
申请号:US16558224
申请日:2019-09-02
发明人: Vipin SURI , Dan Jun LI , Dexue SUN , Byron DELABARRE , Vijaya BALAKRISHNAN , Brian DOLINSKI , Mara Christine INNISS , Grace Y. OLINGER
IPC分类号: C12N9/06 , C07K14/54 , C07K14/715 , C07K14/705 , C12N15/85 , A61K35/17
摘要: The present invention is related to compositions and methods for the regulated and controlled expression of proteins.
-
公开(公告)号:US20220403001A1
公开(公告)日:2022-12-22
申请号:US17251635
申请日:2019-06-12
发明人: Vipin SURI , Celeste RICHARDSON , Brian DOLINSKI , Abhishek KULKARNI , Mara Christine INNISS , Dexue SUN , Dan Jun LI , Grace Y. OLINGER , Scott Francis HELLER , Jennifer Leah GORI , Byron DELABARRE
IPC分类号: C07K14/705 , C12N9/16 , A61K31/53 , A61K31/519 , A61K31/4985
摘要: The present disclosure relates to tunable biocircuit systems for the development of controlled and/or regulated therapeutic systems. In particular, regulatable biocircuits containing destabilizing domains (DD) derived from mutant human cGMP-specific phosphodiesterase type 5 (PDE5) are disclosed. Especially, the present disclosure provides an effector module. Such effector module may include (a) a stimulus response element (SRE), wherein the SRE is a DD, said DD comprising at least one mutation relative to cGMP-specific 3′,5′-cyclic phosphodiesterase (hPDE5; SEQ ID NO: 1) and (b) at least one payload, which is attached, appended or associated with said SRE. The SRE may be responsive to one or more stimuli.
-
公开(公告)号:US20220170011A1
公开(公告)日:2022-06-02
申请号:US17548076
申请日:2021-12-10
摘要: The present disclosure provides compositions and methods related to regulatable Cas systems. Such systems provide for ligand-dependent, modular and tunable Cas protein expression and activity.
-
-
-